SEARCH

SEARCH BY CITATION

References

  • 1
    Gelpí C, Sontheimer EJ, Rodriguez-Sanchez JL. Autoantibodies against a serine tRNA–protein complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci USA 1992; 89:9737 43.
  • 2
    Maddrey WC. Subdivisions of idiopathic autoimmune chronic active hepatitis. Hepatology 1987; 7:1372 5.
  • 3
    Maddrey WC & Willis C. Chronic hepatitis. In: BoneRC, ed. Disease-a-month, Vol XXXIX, No. 2. 1993: 53 126.
  • 4
    Manns M. Autoantibodies and antigens in liver diseases-updated. J Hepatol 1989; 9:272 80.
  • 5
    Czaja AJ. Autoantibodies. Bailliere's Clin Gastroenterol 1995; 9:723 44.
  • 6
    Homberg J-C, Abuaf N, Bernard O et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of ‘autoimmune’ hepatitis. Hepatology 1987; 7:1333 9.
  • 7
    Czaja AJ, Pfeifer K, Decker RH, Vallari A. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci 1996; 41:1733 40.
  • 8
    Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996; 24:1068 73.
  • 9
    Manns MP. Autoantibodies in chronic hepatitis: diagnostic reagents and scientific tools to study aetiology, pathogenesis, and cell biology. Prog Liver Dis 1994; 12:137 56.
  • 10
    Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992; 103:1290 5.
  • 11
    Czaja AJ. Behaviour and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999; 30:394 401.
  • 12
    Czaja AJ & Manns MP. The validity and importance of subtypes of: a point of view. Am J Gastroenterol 1995; 90:1206 11.
  • 13
    Czaja AJ. Autoimmune hepatitis: evolving concepts and treatment strategies. Dig Dis Sci 1995; 40:435 56.
  • 14
    Jung J-E, Karoor V, Sandbaken MG et al. Utilisation of selenocysteyl-tRNA(Ser)Sec and seryl-tRNA(Ser)Sec in protein synthesis. J Biol Chem 1994; 269:29739 45.
  • 15
    Bock A, Forchhammer K, Heider J, Baron C. Selenoprotein synthesis: an expansion of the genetic code. Trends Biochem Sci 1991; 16:463 7.
  • 16
    Yamada K. A new translational elongation factor for selenocysteyl-tRNA in eucaryotes. FEBS Letters 1995; 377:313 7.
  • 17
    Johnson PJ, McFarlane IG, Alvarez F et al. Meeting Report. International Autoimmune Hepatitis Group. Hepatology 1993; 18:998 1005.
  • 18
    Czaja AJ. Diagnosis, prognosis, and treatment of classical autoimmune chronic active hepatitis. In: KrawittEL, WiesnerRH, eds. Autoimmune liver disease. New York: Raven Press, 1991: 143 66.
  • 19
    Summerskill WHJ, Korman MG, Ammon HV, Baggentoss AH. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975; 16:876 83.
  • 20
    Czaja AJ & Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993; 105:1824 32.
  • 21
    Gelpí C, Algueró A, Martinez MA, Vidal S, Juarez C, Rodriguez-Sanchez JL. Identification of protein components reactive with anti-PM/Scl autoantibodies. Clin Exp Immunol 1990; 81:59 64.
  • 22
    Lerner MR & Steitz JA. Antibodies to small nuclear RNAs complex with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979; 76:5495 9.
  • 23
    Mimori T, Hinterberger M, Pettersson I, Steitz JA. Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma–polymyositis overlap syndrome. J Biol Chem 1984; 259:560 5.
  • 24
    Forman MS, Nakamura M, Mimori T, Gelpí C, Hardin JA. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled extracts. Arthritis Rheum 1985; 28:1356 61.
  • 25
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1979; 227:680 5.
  • 26
    Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350 4.
  • 27
    Sambrook J, Fritsch E, Maniatis T. Molecular cloning, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989: 12.16 12.20.
  • 28
    Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463 7.
  • 29
    Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997; 25:3389 402.
  • 30
    Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucl Acids Res 1984; 12:857 72.
  • 31
    Hanas JS, Hazuda DJ, Bogenhagen DF, Wu FY-H, Wu C-W. Xenopus transcription factor A requires zinc for binding to the 5S RNA gene. J Biol Chem 1983; 258:14120 5.
  • 32
    Draper DE. Protein-RNA recognition. Ann Rev Biochem 1995; 64:593 620.
  • 33
    Vincent C, Leberman R, Hartlein M. EMBL/GENBANK/DDBJ Data Banks Accession: P49591.
  • 34
    Mizutani T, Kurata H, Yamada K, Totsuka T. Some properties of murine selenocysteine synthase. Biochem J 1992; 284:827 34.
  • 35
    Yamada K, Mizutani T, Ejiri S, Totsuka T. A factor protecting mammalian [75Se]SeCys-tRNA is different from EF-1α. FEBS Letters 1994; 347:137 42.
  • 36
    Burk RF & Hill KE. Regulation of selenoproteins. Ann Rev Nutr 1993; 13:65 81.
  • 37
    Keene JD. RNA surfaces as functional mimetics of proteins. Chem Biol 1996; 3:505 13.
  • 38
    Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; 7:292 4.
  • 39
    Stechemesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology 1993; 18:1 9.
  • 40
    Wächter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Büschenfelde KH, Manns M. Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol 1990; 11:232 9.
  • 41
    Wesierska-Gadek J, Grimm R, Hitchman E, Penner E. Members of the glutathione-S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology 1998; 114:329 35.